Takeda Pharmaceutical Company Ltd

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: -

Established: 1925-01-01

Employees: -

Market Cap: $47.5B

Website: http://www.takeda.co.jp/

Clinical Trials

An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Trelagliptin
Drug: Alogliptin

First Posted Date: 2016-05-12

Last Posted Date: 2023-12-12

Lead Sponsor: Takeda

Target Recruit Count: 27

Registration Number: NCT02771093

Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants

Phase 1

Terminated

Conditions: Alzheimer Disease
Healthy Volunteers

Interventions: Drug: TAK-071 Placebo
Drug: TAK-071
Drug: Donepezil
Drug: Donepezil Placebo

First Posted Date: 2016-05-11

Last Posted Date: 2019-06-10

Lead Sponsor: Takeda

Target Recruit Count: 179

Registration Number: NCT02769065

Triple Combination Therapy in High Risk Crohn's Disease (CD)

Phase 4

Completed

Conditions: Crohn Disease

Interventions: Drug: Vedolizumab
Drug: Adalimumab
Drug: Methotrexate

First Posted Date: 2016-05-06

Last Posted Date: 2023-07-14

Lead Sponsor: Takeda

Target Recruit Count: 55

Registration Number: NCT02764762

Locations: 🇺🇸
Cotton O'Neil Clinical Research, Topeka, Kansas, United States
🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇨🇦
PerCuro Clinical Research Ltd, Victoria, British Columbia, Canada

and more 29 locations

An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants

Completed

Conditions: Multiple Myeloma

Interventions: Other: No Intervention

First Posted Date: 2016-05-04

Last Posted Date: 2022-02-23

Lead Sponsor: Takeda

Target Recruit Count: 4310

Registration Number: NCT02761187

Locations: 🇺🇸
San Juan Oncology Associates, Farmington, New Mexico, United States
🇺🇸
University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States
🇺🇸
Poudre Valley Health System, Fort Collins, Colorado, United States

and more 130 locations

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Phase 4

Withdrawn

Conditions: Colitis, Ulcerative
Crohn Disease

Interventions: Drug: Caffeine
Drug: Losartan
Drug: Omeprazole
Drug: Dextromethorphan
Drug: Midazolam
Drug: Vedolizumab

First Posted Date: 2016-05-03

Last Posted Date: 2020-10-27

Lead Sponsor: Takeda

Registration Number: NCT02760615

Locations: 🇺🇸
WCCT, Cypress, California, United States
🇺🇸
QPS MRA, Miami, Florida, United States

An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

Completed

Conditions: Diabetes Mellitus

Interventions: Drug: Alogliptin Benzoate

First Posted Date: 2016-04-29

Last Posted Date: 2019-07-10

Lead Sponsor: Takeda

Target Recruit Count: 1409

Registration Number: NCT02756832

Locations: 🇷🇺
City policlinic #3, Tomsk, Russian Federation
🇷🇺
Chita State Medical Academy, Chita, Russian Federation
🇷🇺
City polyclinic #166, Moscow, Russian Federation

and more 47 locations

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Completed

Conditions: Hypertension

Interventions: Drug: Azilsartan Medoxomil

First Posted Date: 2016-04-29

Last Posted Date: 2019-11-20

Lead Sponsor: Takeda

Target Recruit Count: 1945

Registration Number: NCT02756819

Locations: 🇰🇿
Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan
🇰🇿
Kazakh Medical University of Continuing Education, Almaty, Kazakhstan
🇷🇺
Medical center Lotos, Chelyabinsk, Russian Federation

and more 62 locations

Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

Phase 3

Active, not recruiting

Conditions: Healthy Volunteers

Interventions: Drug: Placebo
Biological: Tetravalent Dengue Vaccine (TDV)

First Posted Date: 2016-04-22

Last Posted Date: 2024-06-03

Lead Sponsor: Takeda

Target Recruit Count: 20099

Registration Number: NCT02747927

Locations: 🇨🇴
Centro de Atencion e Investigacion Medica S.A - CAIMED - Aguazul - PPDS-PV, Aguazul, Casanare, Colombia
🇨🇴
Centro de Atencion e Investigacion Medica S.A. - CAIMED - Acacias - PPDS-PV, Acacias, Meta, Colombia
🇳🇮
Universidad Nacional Autonoma de Nicaragua, Leon, Nicaragua

and more 25 locations

Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

Phase 2

Completed

Conditions: Gastroesophageal Reflux

Interventions: Drug: Vonoprazan
Drug: Esomeprazole
Drug: Esomeprazole Placebo

First Posted Date: 2016-04-19

Last Posted Date: 2020-02-18

Lead Sponsor: Takeda

Target Recruit Count: 256

Registration Number: NCT02743949

Locations: 🇪🇪
OU Innomedica, Tallinn, Estonia
🇵🇱
NZOZ Inter-Med, Czestochowa, Poland
🇬🇧
Royal Stoke University Hospital, Stoke on Trent, Staffordshire, United Kingdom

and more 36 locations

Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

Phase 4

Terminated

Conditions: Colitis, Ulcerative
Crohn Disease

Interventions: Drug: Vedolizumab

First Posted Date: 2016-04-19

Last Posted Date: 2023-11-18

Lead Sponsor: Takeda

Target Recruit Count: 331

Registration Number: NCT02743806

Locations: 🇦🇺
The Canberra Hospital, Garran, Australian Capital Territory, Australia
🇦🇺
Western Hospital, Footscray, Victoria, Australia
🇦🇺
Box Hill Hospital, Box Hill, Australia

and more 74 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy